April 16, 2026
By Caitlin Minton-Smith, Senior Product Marketing Manager, MasterControl
Cell and gene therapies account for 40% of all FDA clinical holds despite representing just 2% of trials. Most are driven by adverse events no system can prevent, but 21% are CMC failures that are almost entirely avoidable. This post explains the difference, and why it costs programs an average of 8.4 months.
Why can't you scale successful AI pilots? New research reveals 72% of medical device manufacturers are stuck in hybrid manual-digital operations. Learn about the connectivity crisis that’s likely blocking the scaling of your AI pilots and discover the three critical steps to overcome AI deployment challenges.
75% of CDMOs expect to get value from AI within three years, yet nearly 80% remain in preliminary phases. Discover the No. 1 barrier blocking deployment, where leading CDMOs focus their AI investments, and the strategic roadmap for transforming pilots into production-ready systems.
Not all AI vendors are created equal, and the wrong choice could worsen your integration challenges. Learn how to evaluate new AI-specialized vendors, enhance existing partnerships, and avoid costly mistakes. Get your complete vendor selection framework here.
50% of technology time is wasted on infrastructure issues, not innovation. Discover why integrated systems — the No. 1 AI prerequisite — are also the biggest barrier to deployment, based on insights from 300 life sciences professionals.
March 24, 2026
by Viktoria Rojkova, Vice President of AI/ML and Data Science, MasterControl, Bhavik Agarwal, Machine Learning Research Scientist, MasterControl, and Nidlhi Bendre, AI/ML Co-Op Intern, MasterControl
You shouldn’t have to choose between AI innovation and regulatory compliance. Learn how a deterministic approach can help you achieve 100% accuracy on critical manufacturing data while digitizing batch records in minutes. Discover how structured JSON transforms decades of paper documentation into actionable intelligence.
The talent pool for AI-proficient life sciences professionals is severely limited. Learn how to source, screen, interview, and retain quality candidates who can drive your digital transformation. This comprehensive hiring guide provides actionable strategies for every stage of the recruitment lifecycle.
March 10, 2026
by Matt Lowe, Chief Strategy Officer, MasterControl
Not all FedRAMP claims deliver true authorization. MasterControl CSO Matt Lowe examines the critical differences between FedRAMP Authorized solutions and "FedRAMP-adjacent" alternatives—and what this means for your agency's security and federal compliance.
MasterControl Manufacturing Excellence (Mx) ranked No. 7 on G2's 2026 Best ERP Software list—recognition earned through verified customer reviews. Discover why life sciences manufacturers choose Mx to eliminate production errors, accelerate time to market by 70%, and deliver seamless ERP integration.
Struggling with manual compliance processes? Discover how AI-enhanced quality management systems are helping pharma manufacturers achieve 100% FDA and ISO compliance—without disrupting operations or breaking budgets. Learn practical strategies for transforming compliance from burden to competitive advantage.
The focus has shifted from compliance to operational agility in medical device manufacturing. Four forces are reshaping the industry’s landscape: supply chain regionalization, digital thread mandates, embedded AI, and workforce transformation. Discover how leaders are turning industry changes into competitive advantages.
Digital compliance processes are now competitive differentiators for CDMOs striving to win sponsor contracts. Yet recent data reveals a surprising gap: only 27% of CDMOs have implemented electronic batch records. Discover what sponsors really want and the strategic moves that put contract manufacturing leaders ahead.
Cell and gene therapies are revolutionizing medicine, yet most manufacturers still rely on paper-based processes that can't scale. Discover why digital transformation is essential for CGT success and how to build the right foundation for your operation.
Quality leaders are facing unprecedented change: AI moving from pilot to production, CSA becoming regulatory reality, and inspection-anytime expectations. Learn about these and the other key trends reshaping pharma quality and how to navigate them with confidence.
February 5, 2026
by Betsy Rogers, Senior Product Manager, AI/ML, MasterControl
Managing SOP compliance is increasingly time-consuming, manual, and reactive for quality teams operating in regulated environments. Learn how the new AI-powered SOP Analyzer tool helps identify compliance gaps faster, reduces review burdens, and supports audit readiness.
February 4, 2026
by Jake Ure, Sr. Product Manager, MasterControl
Your QA teams are buried in manual batch reviews while patients wait for therapies. Discover how digital batch disposition transforms this critical bottleneck into a strategic advantage—with practical principles from BioPhorum’s Batch Disposition Manifesto and actionable steps any organization can implement today.
According to LNS Research's independent analysis, MasterControl ranks No. 1 in Growth Potential among Enterprise Quality Management Software (EQMS) vendors. Learn what sets the data-first platform apart and how to select the right quality management solution for your organization.
Most AI initiatives stall at the pilot phase. Discover the AI trends transforming life sciences manufacturing in 2026—from specialized workforce copilots to computer vision achieving 99% accuracy in quality operations.
Life sciences manufacturers are slashing unplanned downtime by 50% with AI-driven predictive maintenance. Explore this and the other critical trends transforming asset management from a reactive cost center into a strategic competitive advantage.
Stuck between basic EBR systems that don't do enough and expensive MES platforms that do too much? Most pharma manufacturers are trapped in this uncomfortable middle ground, struggling with data silos, higher error rates, and systems that can't keep up with modern production demands. Discover the emerging solution category that's helping pharma manufacturers bridge this gap and get an evaluation framework to choose the right fit for you.
